NO20024155L - Fremgangsmåte for fremstilling av fosforotioattriestere - Google Patents
Fremgangsmåte for fremstilling av fosforotioattriestereInfo
- Publication number
- NO20024155L NO20024155L NO20024155A NO20024155A NO20024155L NO 20024155 L NO20024155 L NO 20024155L NO 20024155 A NO20024155 A NO 20024155A NO 20024155 A NO20024155 A NO 20024155A NO 20024155 L NO20024155 L NO 20024155L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- phosphorothioate esters
- phosphonate
- alcohol
- phosphorothioate
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 title 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
- 108091034117 Oligonucleotide Proteins 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000008878 coupling Effects 0.000 abstract 1
- 239000007822 coupling agent Substances 0.000 abstract 1
- 238000010168 coupling process Methods 0.000 abstract 1
- 238000005859 coupling reaction Methods 0.000 abstract 1
- 239000002777 nucleoside Substances 0.000 abstract 1
- 125000003835 nucleoside group Chemical group 0.000 abstract 1
- -1 phosphorothioate triester Chemical class 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/16—Esters of thiophosphoric acids or thiophosphorous acids
- C07F9/165—Esters of thiophosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Luminescent Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0004889.2A GB0004889D0 (en) | 2000-03-01 | 2000-03-01 | Synthesis of oligonucleotides |
| PCT/GB2001/000764 WO2001064702A1 (en) | 2000-03-01 | 2001-02-23 | Process for the preparation of phosphorothioate triesters |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20024155D0 NO20024155D0 (no) | 2002-08-30 |
| NO20024155L true NO20024155L (no) | 2002-10-24 |
Family
ID=9886705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20024155A NO20024155L (no) | 2000-03-01 | 2002-08-30 | Fremgangsmåte for fremstilling av fosforotioattriestere |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US7022833B2 (no) |
| EP (1) | EP1272501B1 (no) |
| JP (1) | JP2003525305A (no) |
| KR (1) | KR20030032924A (no) |
| CN (1) | CN1262557C (no) |
| AT (1) | ATE266037T1 (no) |
| AU (2) | AU3576601A (no) |
| BR (1) | BR0108771A (no) |
| CA (1) | CA2401083A1 (no) |
| CZ (1) | CZ20022930A3 (no) |
| DE (1) | DE60103145T2 (no) |
| DK (1) | DK1272501T3 (no) |
| ES (1) | ES2220721T3 (no) |
| GB (1) | GB0004889D0 (no) |
| HU (1) | HUP0204249A3 (no) |
| IL (1) | IL151238A0 (no) |
| MX (1) | MXPA02008530A (no) |
| NO (1) | NO20024155L (no) |
| NZ (1) | NZ520778A (no) |
| PL (1) | PL362067A1 (no) |
| WO (1) | WO2001064702A1 (no) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9717158D0 (en) * | 1997-08-13 | 1997-10-22 | King S College London | Solution synthesis of oligonucleotides and their phosphorothioate analogues |
| WO2003045969A1 (en) * | 2001-11-21 | 2003-06-05 | Avecia Biotechnology Inc. | Coupling reagent for h-phosphonate chemistry |
| EP1386925A1 (en) | 2002-07-31 | 2004-02-04 | Girindus AG | Method for preparing oligonucleotides |
| GB0229423D0 (en) * | 2002-12-18 | 2003-01-22 | Avecia Ltd | Process |
| BRPI0923225A2 (pt) | 2008-12-02 | 2016-10-04 | Chiralgen Ltd | metodo para sintese de acidos nucleicos modificados no atomo de fosforo |
| KR101885383B1 (ko) | 2009-07-06 | 2018-08-03 | 웨이브 라이프 사이언시스 리미티드 | 신규한 핵산 프로드러그 및 그의 사용 방법 |
| JP5868324B2 (ja) | 2010-09-24 | 2016-02-24 | 株式会社Ｗａｖｅ Ｌｉｆｅ Ｓｃｉｅｎｃｅｓ Ｊａｐａｎ | 不斉補助基 |
| CN103796657B (zh) | 2011-07-19 | 2017-07-11 | 波涛生命科学有限公司 | 合成官能化核酸的方法 |
| EP4219516A3 (en) | 2012-07-13 | 2024-01-10 | Wave Life Sciences Ltd. | Chiral control |
| SG11201500239VA (en) | 2012-07-13 | 2015-03-30 | Wave Life Sciences Japan | Asymmetric auxiliary group |
| EP2873674B1 (en) | 2012-07-13 | 2020-05-06 | Shin Nippon Biomedical Laboratories, Ltd. | Chiral nucleic acid adjuvant |
| WO2015108047A1 (ja) | 2014-01-15 | 2015-07-23 | 株式会社新日本科学 | 免疫誘導活性を有するキラル核酸アジュバンド及び免疫誘導活性剤 |
| JPWO2015108048A1 (ja) | 2014-01-15 | 2017-03-23 | 株式会社新日本科学 | 抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤 |
| US10322173B2 (en) | 2014-01-15 | 2019-06-18 | Shin Nippon Biomedical Laboratories, Ltd. | Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent |
| KR102423317B1 (ko) | 2014-01-16 | 2022-07-22 | 웨이브 라이프 사이언시스 리미티드 | 키랄 디자인 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9501465D0 (en) | 1995-01-25 | 1995-03-15 | King S College London | Nucleoside phosphorothioate derivatives,synthesis and use thereof |
| US6096881A (en) * | 1997-05-30 | 2000-08-01 | Hybridon, Inc. | Sulfur transfer reagents for oligonucleotide synthesis |
| GB9717158D0 (en) | 1997-08-13 | 1997-10-22 | King S College London | Solution synthesis of oligonucleotides and their phosphorothioate analogues |
| GB9924285D0 (en) | 1999-10-14 | 1999-12-15 | Avecia Ltd | Process |
-
2000
- 2000-03-01 GB GBGB0004889.2A patent/GB0004889D0/en not_active Ceased
-
2001
- 2001-02-23 CA CA002401083A patent/CA2401083A1/en not_active Abandoned
- 2001-02-23 NZ NZ520778A patent/NZ520778A/en unknown
- 2001-02-23 AU AU3576601A patent/AU3576601A/xx active Pending
- 2001-02-23 AT AT01907898T patent/ATE266037T1/de not_active IP Right Cessation
- 2001-02-23 WO PCT/GB2001/000764 patent/WO2001064702A1/en not_active Application Discontinuation
- 2001-02-23 MX MXPA02008530A patent/MXPA02008530A/es not_active Application Discontinuation
- 2001-02-23 EP EP01907898A patent/EP1272501B1/en not_active Expired - Lifetime
- 2001-02-23 PL PL36206701A patent/PL362067A1/xx unknown
- 2001-02-23 AU AU2001235766A patent/AU2001235766B2/en not_active Ceased
- 2001-02-23 CZ CZ20022930A patent/CZ20022930A3/cs unknown
- 2001-02-23 ES ES01907898T patent/ES2220721T3/es not_active Expired - Lifetime
- 2001-02-23 CN CNB018058906A patent/CN1262557C/zh not_active Expired - Fee Related
- 2001-02-23 BR BR0108771-1A patent/BR0108771A/pt not_active IP Right Cessation
- 2001-02-23 DK DK01907898T patent/DK1272501T3/da active
- 2001-02-23 KR KR1020027011442A patent/KR20030032924A/ko not_active Application Discontinuation
- 2001-02-23 US US10/220,353 patent/US7022833B2/en not_active Expired - Lifetime
- 2001-02-23 DE DE60103145T patent/DE60103145T2/de not_active Expired - Fee Related
- 2001-02-23 HU HU0204249A patent/HUP0204249A3/hu unknown
- 2001-02-23 IL IL15123801A patent/IL151238A0/xx unknown
- 2001-02-23 JP JP2001564195A patent/JP2003525305A/ja active Pending
-
2002
- 2002-08-30 NO NO20024155A patent/NO20024155L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2003525305A (ja) | 2003-08-26 |
| EP1272501B1 (en) | 2004-05-06 |
| HUP0204249A2 (hu) | 2003-04-28 |
| ATE266037T1 (de) | 2004-05-15 |
| GB0004889D0 (en) | 2000-04-19 |
| US7022833B2 (en) | 2006-04-04 |
| NZ520778A (en) | 2004-05-28 |
| US20030099981A1 (en) | 2003-05-29 |
| CN1406242A (zh) | 2003-03-26 |
| IL151238A0 (en) | 2003-04-10 |
| CN1262557C (zh) | 2006-07-05 |
| AU3576601A (en) | 2001-09-12 |
| NO20024155D0 (no) | 2002-08-30 |
| BR0108771A (pt) | 2002-11-26 |
| DE60103145D1 (de) | 2004-06-09 |
| ES2220721T3 (es) | 2004-12-16 |
| KR20030032924A (ko) | 2003-04-26 |
| EP1272501A1 (en) | 2003-01-08 |
| HUP0204249A3 (en) | 2004-08-30 |
| DE60103145T2 (de) | 2005-05-04 |
| CA2401083A1 (en) | 2001-09-07 |
| PL362067A1 (en) | 2004-10-18 |
| WO2001064702A1 (en) | 2001-09-07 |
| DK1272501T3 (da) | 2004-08-16 |
| AU2001235766B2 (en) | 2005-01-27 |
| CZ20022930A3 (cs) | 2002-11-13 |
| MXPA02008530A (es) | 2003-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ502684A (en) | Solution phase synthesis of phosphorothioate triesters | |
| NO20024155D0 (no) | Fremgangsmåte for fremstilling av fosforotioattriestere | |
| DE60144479D1 (no) | ||
| NO20030422L (no) | Vaginal avlevering av bisfosfonater | |
| ES2173056T1 (es) | Forma cristalina i de la claritromicina. | |
| NO20031922L (no) | Faseoverföringskatalysert glykosidering av en indolkarbazol | |
| AU7803500A (en) | Process for the preparation of phosphorothioate triesters and oligonucleotides | |
| AU2203801A (en) | Formulations of adenosine a1 agonists | |
| AU2203601A (en) | Formulations of adenosine a1 agonists | |
| AU2001250858A1 (en) | Methods of preparing amplified nucleic acid molecules | |
| AU2001262141A1 (en) | Use of CDP-choline for the treatment of alcohol withdrawal syndrome | |
| AU2001214115A1 (en) | Process for the preparation of anhydrous azithromycin | |
| IT1307383B1 (it) | Giunto elastico per alberi coassiali | |
| NO20025703L (no) | Fremgangsmåte for fremstilling av vannfritt natriumperklorat | |
| AU2204001A (en) | Formulations of adenosine a1 agonists | |
| GB9924766D0 (en) | New use of acetyl salicilic acid | |
| AU2001233246A1 (en) | Novel use of ribozymes to block gene expression | |
| HUP0100910A2 (en) | Microbial process for preparation of optically active 3-hydroxy pirrolidine derivatives | |
| AU3355600A (en) | Isolation of nucleic acid molecules | |
| SE0003236D0 (sv) | Procedure for treatment of autism by inhibition of post-proline-cleaving enzymes | |
| AU2001215557A1 (en) | Method of designing the molecular structure of inhibitor to enzyme | |
| AU2002239511A1 (en) | Haplotypes of the gsr gene | |
| HUP0103642A3 (en) | Process for the preparation of 3-hydroxybenzyl alcohol |